120 related articles for article (PubMed ID: 32449285)
1. Recessive ACO2 variants as a cause of isolated ophthalmologic phenotypes.
Gibson S; Azamian MS; Lalani SR; Yen KG; Sutton VR; Scott DA
Am J Med Genet A; 2020 Aug; 182(8):1960-1966. PubMed ID: 32449285
[TBL] [Abstract][Full Text] [Related]
2. Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometabolic syndrome.
Sharkia R; Wierenga KJ; Kessel A; Azem A; Bertini E; Carrozzo R; Torraco A; Goffrini P; Ceccatelli Berti C; McCormick ME; Plecko B; Klein A; Abela L; Hengel H; Schöls L; Shalev S; Khayat M; Mahajnah M; Spiegel R
J Inherit Metab Dis; 2019 Mar; 42(2):264-275. PubMed ID: 30689204
[TBL] [Abstract][Full Text] [Related]
3. Novel compound heterozygous ACO2 mutations in an infant with progressive encephalopathy: A newly identified neurometabolic syndrome.
Park JS; Kim MJ; Kim SY; Lim BC; Kim KJ; Seong MW; Lee JS; Chae JH
Brain Dev; 2020 Oct; 42(9):680-685. PubMed ID: 32713659
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy.
Metodiev MD; Gerber S; Hubert L; Delahodde A; Chretien D; Gérard X; Amati-Bonneau P; Giacomotto MC; Boddaert N; Kaminska A; Desguerre I; Amiel J; Rio M; Kaplan J; Munnich A; Rötig A; Rozet JM; Besmond C
J Med Genet; 2014 Dec; 51(12):834-8. PubMed ID: 25351951
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy.
Neumann MA; Grossmann D; Schimpf-Linzenbold S; Dayan D; Stingl K; Ben-Menachem R; Pines O; Massart F; Delcambre S; Ghelfi J; Bohler J; Strom T; Kessel A; Azem A; Schöls L; Grünewald A; Wissinger B; Krüger R
Sci Rep; 2020 Oct; 10(1):16736. PubMed ID: 33028849
[TBL] [Abstract][Full Text] [Related]
6. Dominant
Charif M; Gueguen N; Ferré M; Elkarhat Z; Khiati S; LeMao M; Chevrollier A; Desquiret-Dumas V; Goudenège D; Bris C; Kane S; Alban J; Chupin S; Wetterwald C; Caporali L; Tagliavini F; LaMorgia C; Carbonelli M; Jurkute N; Barakat A; Gohier P; Verny C; Barth M; Procaccio V; Bonneau D; Zanlonghi X; Meunier I; Weisschuh N; Schimpf-Linzenbold S; Tonagel F; Kellner U; Yu-Wai-Man P; Carelli V; Wissinger B; Amati-Bonneau P; Reynier P; ; Lenaers G
Brain Commun; 2021; 3(2):fcab063. PubMed ID: 34056600
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Infantile Cerebellar-Retinal Degeneration With Compound Heterozygous Variants in
Ha DJ; Park J; Seo GH; Lee K; Kwon YS; Lee JE; Kim SJ
Front Genet; 2022; 13():729980. PubMed ID: 35368710
[TBL] [Abstract][Full Text] [Related]
8. Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2.
Blackburn PR; Schultz MJ; Lahner CA; Li D; Bhoj E; Fisher LJ; Renaud DL; Kenney A; Ibrahim N; Hashem M; Zain Seidahmed M; Hasadsri L; Schrier Vergano SA; Alkuraya FS; Lanpher BC
Ann Clin Transl Neurol; 2020 Jun; 7(6):1013-1028. PubMed ID: 32519519
[TBL] [Abstract][Full Text] [Related]
9. Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency.
Sadat R; Barca E; Masand R; Donti TR; Naini A; De Vivo DC; DiMauro S; Hanchard NA; Graham BH
Mol Genet Metab; 2016 May; 118(1):28-34. PubMed ID: 26992325
[TBL] [Abstract][Full Text] [Related]
10. ACO2 clinicobiological dataset with extensive phenotype ontology annotation.
Guehlouz K; Foulonneau T; Amati-Bonneau P; Charif M; Colin E; Bris C; Desquiret-Dumas V; Milea D; Gohier P; Procaccio V; Bonneau D; den Dunnen JT; Lenaers G; Reynier P; Ferré M
Sci Data; 2021 Aug; 8(1):205. PubMed ID: 34354088
[TBL] [Abstract][Full Text] [Related]
11. Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2.
Spiegel R; Pines O; Ta-Shma A; Burak E; Shaag A; Halvardson J; Edvardson S; Mahajna M; Zenvirt S; Saada A; Shalev S; Feuk L; Elpeleg O
Am J Hum Genet; 2012 Mar; 90(3):518-23. PubMed ID: 22405087
[TBL] [Abstract][Full Text] [Related]
12. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant.
Srivastava S; Gubbels CS; Dies K; Fulton A; Yu T; Sahin M
J Child Neurol; 2017 Aug; 32(9):840-845. PubMed ID: 28545339
[TBL] [Abstract][Full Text] [Related]
13. A sibling study of isolated optic neuropathy associated with novel variants in the ACO2 gene.
Kelman JC; Kamien BA; Murray NC; Goel H; Fraser CL; Grigg JR
Ophthalmic Genet; 2018 Oct; 39(5):648-651. PubMed ID: 30118607
[TBL] [Abstract][Full Text] [Related]
14. Child Neurology: Progressive Cerebellar Atrophy and Retinal Dystrophy: Clues to an Ultrarare
Lail N; Pandey AK; Venkatesh S; Noland RD; Swanson G; Pain D; Branson HM; Suzuki CK; Yoon G
Neurology; 2023 Oct; 101(15):e1567-e1571. PubMed ID: 37460232
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel compound heterozygous mutations in ACO2 in a patient with progressive cerebral and cerebellar atrophy.
Fukada M; Yamada K; Eda S; Inoue K; Ohba C; Matsumoto N; Saitsu H; Nakayama A
Mol Genet Genomic Med; 2019 Jul; 7(7):e00698. PubMed ID: 31106992
[TBL] [Abstract][Full Text] [Related]
16. Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiency.
Abela L; Spiegel R; Crowther LM; Klein A; Steindl K; Papuc SM; Joset P; Zehavi Y; Rauch A; Plecko B; Simmons TL
PLoS One; 2017; 12(5):e0176363. PubMed ID: 28463998
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing identifies novel missense and deletion variants in RTN4IP1 associated with optic atrophy, global developmental delay, epilepsy, ataxia, and choreoathetosis.
D'Gama AM; England E; Madden JA; Shi J; Chao KR; Wojcik MH; Torres AR; Tan WH; Berry GT; Prabhu SP; Agrawal PB
Am J Med Genet A; 2021 Jan; 185(1):203-207. PubMed ID: 33037779
[TBL] [Abstract][Full Text] [Related]
18. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization on muscle tissue of a novel biallelic
Ricci FS; Stanga S; Mezzanotte M; Marinaccio C; D'Alessandro R; Somà A; Sottemano S; Conio A; Morana G; Spada M; Boido M; Mongini TE
JIMD Rep; 2024 Jan; 65(1):3-9. PubMed ID: 38186851
[TBL] [Abstract][Full Text] [Related]
20. Neurologic Phenotypes Associated With Mutations in RTN4IP1 (OPA10) in Children and Young Adults.
Charif M; Nasca A; Thompson K; Gerber S; Makowski C; Mazaheri N; Bris C; Goudenège D; Legati A; Maroofian R; Shariati G; Lamantea E; Hopton S; Ardissone A; Moroni I; Giannotta M; Siegel C; Strom TM; Prokisch H; Vignal-Clermont C; Derrien S; Zanlonghi X; Kaplan J; Hamel CP; Leruez S; Procaccio V; Bonneau D; Reynier P; White FE; Hardy SA; Barbosa IA; Simpson MA; Vara R; Perdomo Trujillo Y; Galehdari H; Deshpande C; Haack TB; Rozet JM; Taylor RW; Ghezzi D; Amati-Bonneau P; Lenaers G
JAMA Neurol; 2018 Jan; 75(1):105-113. PubMed ID: 29181510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
